Study title: Large scale safety study of the DTacP-IPV {acellular TETRACOQ®) vaccine, administered in combination (one injection site) or in assocation two injection sites) with Haemophilus influenzae Type b vaccine (Act-HIB®) for primary and booster immunisation
Type of medicine: Non-centrally authorised vaccines | |||||
Therapeutic area: Virus Diseases [C02] | |||||
Brands: Please see report, Please see report, Please see report, Please see report, Please see report | |||||
MAH holders: Please see report, Please see report, Please see report, Please see report, Please see report | |||||
Assessment: | |||||
Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) | |||||
ATC code: J07BF03 | |||||
Document link: | |||||
Document date: | |||||
Study number: E2I02394 | |||||
EudraCT number: | |||||
Scope of study: CLINICAL | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |